The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The recent passage of the Inflation Reduction Act of 2022 (IRA) includes a number of climate, tax, and health care provisions and prescription drug reforms. This policy watch explores the potential impacts of the Inflation Reduction Act on overall Medicaid spending as well as implications for Medicaid beneficiaries.
March 4, 2021 – THE CONVERSATION: Between Us, About Us. is a new campaign to provide Black communities with credible information about the COVID-19 vaccines co-developed by KFF (Kaiser Family Foundation) and the Black Coalition Against COVID.
A new KFF brief analyzes how the accessibility and cost of COVID-19 vaccines, treatments, and tests will change after the current government supply is depleted and the public health emergency ends. The Biden Administration has announced that it will have to end its purchase and distribution of COVID supplies as government funding is depleted.
On Wednesday, October 19th, a panel of experts joined series moderator Larry Levitt in a 45-minute discussion exploring the government’s plan to transition the distribution of COVID tests, vaccines, and therapeutics to the commercial market and its potential implications for consumers and insurers.
This analysis uses CDC data to look at deaths from COVID-19 for adults 65 and older. The findings show that deaths for older adults doubled from April to July 2022 and stayed high in August, before dropping again in September.
This post reviews the latest information on state priorities for their initial COVID-19 vaccine allocations to assess which populations will get the vaccine first.
As the first doses of the new COVID-19 vaccine are delivered to health care workers and other early recipients, many Americans are eager to know not only when the vaccine will be available to them but also whether they will be able to get it at no cost.
With planning beginning for an eventual COVID-19 vaccine, one important consideration is making sure that distribution processes and outreach and communication strategies reach people of color. Analysis of seasonal flu vaccination rates provides some insight into the potential barriers and issues to be addressed as part of COVID-19 vaccination efforts.
When a COVID-19 vaccine becomes available, all or most people living in the country will need to get vaccinated in order to maximize its benefits and provide adequate immunity nationwide.
The first Americans were vaccinated today as COVID-19 vaccines are being distributed across the country.
© 2026 KFF